Viral Vector Production (Research-use) Market size to Reach USD 3.13 Billion by 2031 Driven by Expanding Gene Therapy Research

Mordor Intelligence has published a new report on the viral vector production (research-use) market, offering a comprehensive analysis of trends, growth drivers, and future projections
Introduction

According to Mordor Intelligence, the viral vector production (research-use) market size [https://www.mordorintelligence.com/industry-reports/viral-vector-production-research-use-market?utm_source=abnewswire] was valued at USD 1.25 billion in 2025 and is expected to grow to USD 1.46 billion in 2026, reaching USD 3.13 billion by 2031, registering a CAGR of 16.52% during the forecast period. This growth reflects the rising reliance on viral vectors in preclinical and early-stage clinical research across multiple therapeutic areas.

The increasing number of gene therapy pipelines, with thousands of ongoing research programs, is a major factor shaping the viral vector production (research-use) market growth. Academic institutes, biotechnology firms, and pharmaceutical companies are actively investing in research-use viral vectors to support innovation.

Key Trends in the Viral Vector Production (Research-use) Market

Rising Demand from Gene and Cell Therapy Research

One of the most important viral vector production (research-use) market trends is the increasing demand from gene and cell therapy research programs. Viral vectors are essential tools for delivering genetic material into cells, making them critical for early-stage research. As more therapies enter preclinical and clinical development, the demand for research-grade vectors continues to rise.

Expansion of Contract Manufacturing Capabilities

Another key trend in the viral vector production (research-use) market forecast is the rapid expansion of contract development and manufacturing organizations. These service providers are scaling up facilities and offering integrated solutions that include vector design, production, purification, and testing. This shift allows research organizations to focus on innovation while outsourcing complex manufacturing tasks.

Adoption of Integrated and Automated Production Systems

Automation and integrated production platforms are becoming more common across the viral vector production (research-use) industry. Closed systems and automated processes help reduce contamination risks and improve consistency. In addition, digital tools such as modeling and simulation are being used to optimize production workflows and improve efficiency.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/viral-vector-production-research-use-market?utm_source=abnewswire

Viral Vector Production (Research-use) Market Segmentation

By Vector Type

*
Adeno-Associated Virus (AAV)

*
Adenoviral Vectors

*
Lentiviral Vectors

*
Retroviral Vectors

*
Other Vector Types

By Application

*
Cell & Gene Therapy Research

*
Vaccine Studies

*
Oncolytic Virus Research

*
Other Applications

By End User

*
Pharmaceutical & Biotechnology Companies

*
Contract Development & Manufacturing Organizations (CDMOs)

*
Academic Centers & Research Institutes

*
Contract Research Organizations (CROs)

By Geography

*
North America

*
Europe

*
Asia-Pacific

*
Middle East & Africa

*
South America

Key Players in the Viral Vector Production (Research-use) Market

The viral vector production (research-use) market share is influenced by a mix of established global companies and specialized service providers. Market participants are focusing on expanding their capabilities through acquisitions, partnerships, and technology integration.

Leading Companies

*
Merck KGaA

*
Lonza

*
Thermo Fisher Scientific Inc.

*
FUJIFILM Diosynth Biotechnologies

*
Charles River Laboratories

Conclusion

The viral vector production (research-use) market forecast remains positive as demand from gene therapy and vaccine research continues to expand. The growing number of research programs and increasing collaboration between academic institutions and industry players are expected to sustain market momentum.

At the same time, improvements in manufacturing technologies and the expansion of contract manufacturing services are helping to address existing challenges. While issues such as production complexity and raw material constraints persist, ongoing investments in innovation are expected to improve efficiency and scalability.

Industry Related Reports

ADC Drug CDMO Service Market:

The market is growing due to increasing demand for targeted cancer therapies, rising outsourcing of complex drug development, and advancements in antibody-drug conjugate technologies.

Get more insights: https://www.mordorintelligence.com/industry-reports/adc-drug-cdmo-service-market?utm_source=abnewswire

Advanced Drug Delivery CDMO Market size:

The market is projected to grow from USD 8.96 billion in 2026 to USD 21.06 billion by 2031 at a CAGR of 18.64%, driven by increasing demand for innovative drug delivery systems and outsourcing by pharmaceutical companies.

Get more insights: https://www.mordorintelligence.com/industry-reports/advanced-drug-delivery-cdmo-market?utm_source=abnewswire

Inhalation CDMO Market share:

The market is expected to expand from USD 2.41 billion in 2026 to USD 3.44 billion by 2031 at a CAGR of 7.54%, fueled by rising respiratory diseases and growing demand for inhalation-based drug delivery solutions.

Get more insights: https://www.mordorintelligence.com/industry-reports/inhalation-cdmo-market?utm_source=abnewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com https://www.mordorintelligence.com/

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=viral-vector-production-researchuse-market-size-to-reach-usd-313-billion-by-2031-driven-by-expanding-gene-therapy-research]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.